WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
฿ 5,15
arrow_downward
-0,96%(-0,050) 1D
15 de out., 15:23:25 GMT+7 · THB
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para WUXI06…
Abrir
฿ 5,25
Alta
฿ 5,35
Baixa
฿ 5,15
Valor de mercado
200,24 bi
Volume médio
93,60 mil
Volume
281,26 mil
Alto — 52 sem
฿ 6,25
Baixo — 52 sem
฿ 3,02
Ações em circulação
4,12 bi
Nº de funcionários
15 mil
Abrir
฿ 5,25
Alta
฿ 5,35
Baixa
฿ 5,15
Valor de mercado
200,24 bi
Volume médio
93,60 mil
Volume
281,26 mil
Alto — 52 sem
฿ 6,25
Baixo — 52 sem
฿ 3,02
Ações em circulação
4,12 bi
Nº de funcionários
15 mil
Notícias
De fontes da web e parceiros de notícias
Times Brasil | CNBC
·
há 1 dia
S&P 500 fecha estável após balanços de grandes bancos e queda de ações de chips de memória
Vietnam.vn
·
há 6 horas
Resumo Rápido 15-10: S&P 500 sofre maior queda desde julho após divulgação de dados de inflação; lucro da PV GAS nos primeiros nove meses do ano quase dobra a meta anual.
Times Brasil | CNBC
·
há 11 horas
S&P 500 recua 1% com inflação acima do esperado e queda de ações ligadas à IA
Perfil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Sobre Wuxi Biologics (Cayman) Inc. KKPS DR